ZBH

SEC source: 0001757216-26-000004 · form4-02252026_010250.xml · derivative · entry 3

Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,995

Underlying: Common Stock · 15,996 shares

Expires 2026-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

SEC source: 0001757216-26-000004 · form4-02252026_010250.xml · nonDerivative · entry 2

Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,149

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001757216-26-000004 · form4-02252026_010250.xml · nonDerivative · entry 1

Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 246 shares acquired under the Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025.

SEC source: 0001852191-26-000002 · form4-02232026_100236.xml · derivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,935

Underlying: Common Stock · 3,935 shares

Expires 2026-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F2 · shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 3,935 RSUs, which will vest on March 6, 2026.

F2 · derivative.underlying_shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 3,935 RSUs, which will vest on March 6, 2026.

SEC source: 0001864818-26-000002 · form4-02232026_100231.xml · derivative · entry 1

VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,843

Underlying: Common Stock · 4,843 shares

Expires 2026-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F2 · shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 4,843 RSUs, which will vest on March 6, 2026.

F2 · derivative.underlying_shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 4,843 RSUs, which will vest on March 6, 2026.

SEC source: 0001533149-26-000003 · form4-02232026_100241.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,217

Underlying: Common Stock · 10,217 shares

Expires 2026-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F2 · shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 10,217 RSUs, which will vest on March 6, 2026.

F2 · derivative.underlying_shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 10,217 RSUs, which will vest on March 6, 2026.

SEC source: 0001714585-26-000002 · form4-02232026_100256.xml · derivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller, CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,363

Underlying: Common Stock · 1,363 shares

Expires 2026-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F2 · shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 1,363 RSUs, which will vest on March 6, 2026.

F2 · derivative.underlying_shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 1,363 RSUs, which will vest on March 6, 2026.

SEC source: 0001346672-26-000002 · form4-02232026_100203.xml · derivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Chief Legal · Corporate Affairs & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,692

Underlying: Common Stock · 4,692 shares

Expires 2026-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F2 · shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 4,692 RSUs, which will vest on March 6, 2026.

F2 · derivative.underlying_shares: On March 6, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 4,692 RSUs, which will vest on March 6, 2026.

SEC source: 0001635943-26-000004 · form4-02232026_100224.xml · derivative · entry 1

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,050

Underlying: Common Stock · 7,050 shares

Expires 2026-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On March 6, 2023, and on September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 5,298 RSUs for March and 1,752 RSUs for September, totaling 7,050 RSUs, which will vest on March 6, 2026.

F2 · derivative.underlying_shares: On March 6, 2023, and on September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 5,298 RSUs for March and 1,752 RSUs for September, totaling 7,050 RSUs, which will vest on March 6, 2026.

SEC source: 0001757216-26-000002 · form4-02232026_100236.xml · derivative · entry 1

Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,436

Underlying: Common Stock · 24,436 shares

Expires 2026-03-06

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F2 · shares: On March 6, 2023, and on September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned for both such grants to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 12,184 RSUs for March and 12,252 RSUs for September, totaling 24,436 RSUs, which will vest on March 6, 2026.

F2 · derivative.underlying_shares: On March 6, 2023, and on September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned for both such grants to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 12,184 RSUs for March and 12,252 RSUs for September, totaling 24,436 RSUs, which will vest on March 6, 2026.

SEC source: 0001635943-26-000002 · form4-02172026_090203.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,670

F1 · balance_after: Includes 86 shares acquired under the Employee Stock Purchase Plan on December 31, 2025.

SEC source: 0001999146-26-000002 · form4-01052026_090126.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500.354

Underlying: Common Stock · 152.22 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 5.625 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001142083-26-000002 · form4-01052026_090134.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,967.099

Underlying: Common Stock · 304.439 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 85.437 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001587868-26-000002 · form4-01052026_090155.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,275.465

Underlying: Common Stock · 373.63 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 26.117 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001910621-26-000002 · form4-01052026_090111.xml · derivative · entry 1

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,769.983

Underlying: Common Stock · 152.22 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.876 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001689392-26-000002 · form4-01052026_090129.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,579.523

Underlying: Common Stock · 172.977 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 12.952 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001222676-26-000002 · form4-01052026_090146.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,586.952

Underlying: Common Stock · 304.439 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 74.943 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001485164-26-000002 · form4-01052026_090157.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,775.682

Underlying: Common Stock · 415.144 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 41.590 phantom stock units accrued on October 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001852191-25-000003 · form4-12032025_091235.xml · derivative · entry 6

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,688.305

Underlying: Common Stock · 122.695 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F1 · shares: Represents the number of restricted stock units ("RSUs") having a value sufficient to cover certain tax withholding obligations as described in footnote (2) below.

F5 · derivative.exercise_date: Of the remaining RSUs, 1,844.636 vest on February 20, 2026 and 1,843.669 vest on February 20, 2027.

F5 · derivative.expiration_date: Of the remaining RSUs, 1,844.636 vest on February 20, 2026 and 1,843.669 vest on February 20, 2027.

SEC source: 0001852191-25-000003 · form4-12032025_091235.xml · derivative · entry 5

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,699.466

Underlying: Common Stock · 56.534 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F1 · shares: Represents the number of restricted stock units ("RSUs") having a value sufficient to cover certain tax withholding obligations as described in footnote (2) below.

F4 · derivative.exercise_date: The remaining RSUs vest on March 6, 2026.

F4 · derivative.expiration_date: The remaining RSUs vest on March 6, 2026.

SEC source: 0001852191-25-000003 · form4-12032025_091235.xml · nonDerivative · entry 4

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,833

F2 · shares: Represents units withheld from an RSU award held by the reporting person to satisfy FICA and related taxes associated with the retirement eligibility of the reporting person under the terms of such award.

SEC source: 0001852191-25-000003 · form4-12032025_091235.xml · nonDerivative · entry 3

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,955.695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the number of restricted stock units ("RSUs") having a value sufficient to cover certain tax withholding obligations as described in footnote (2) below.

SEC source: 0001852191-25-000003 · form4-12032025_091235.xml · nonDerivative · entry 2

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,833

F2 · shares: Represents units withheld from an RSU award held by the reporting person to satisfy FICA and related taxes associated with the retirement eligibility of the reporting person under the terms of such award.

SEC source: 0001852191-25-000003 · form4-12032025_091235.xml · nonDerivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,889.534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the number of restricted stock units ("RSUs") having a value sufficient to cover certain tax withholding obligations as described in footnote (2) below.

SEC source: 0001533149-25-000007 · form4-11122025_091137.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,632 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: Earned performance-based RSUs vested on November 10, 2025.

F3 · derivative.expiration_date: Earned performance-based RSUs vested on November 10, 2025.

SEC source: 0001533149-25-000007 · form4-11122025_091137.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,754

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of the restricted stock units ("RSUs").

SEC source: 0001533149-25-000007 · form4-11122025_091137.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001533149-25-000005 · form4-11032025_101125.xml · derivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,632

Underlying: Common Stock · 10,632 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of October 1, 2024 to September 30, 2025. As determined on October 24, 2025, based on actual performance, the reporting person earned 10,632 RSUs with a scheduled vesting date of November 10, 2025.

F3 · derivative.exercise_date: Earned RSUs vest on November 10, 2025.

F3 · derivative.expiration_date: Earned RSUs vest on November 10, 2025.

SEC source: 0001999146-25-000003 · form4-10022025_091003.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,342.509

Underlying: Common Stock · 140.163 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 5.316 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001910621-25-000004 · form4-10022025_091026.xml · derivative · entry 1

Kurdikar Devdatt · CIK 0001910621 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,613.887

Underlying: Common Stock · 140.163 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.428 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001689392-25-000004 · form4-10022025_091043.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,393.594

Underlying: Common Stock · 159.276 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Securities is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 13.119 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001587868-25-000008 · form4-10022025_091005.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,875.718

Underlying: Common Stock · 344.036 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 26.33 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001142083-25-000004 · form4-10022025_091019.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,577.223

Underlying: Common Stock · 280.326 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 90.68 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001222676-25-000005 · form4-10022025_091038.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,207.57

Underlying: Common Stock · 280.326 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 79.18 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001485164-25-000007 · form4-10022025_091057.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,318.948

Underlying: Common Stock · 382.263 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 42.678 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

SEC source: 0001635943-25-000004 · form4-09152025_080944.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,584

F1 · balance_after: Includes 160 shares acquired under the Employee Stock Purchase Plan on June 30, 2025.

SEC source: 0001415889-25-024090 · form4-09102025_080947.xml · nonDerivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,833

F1 · price: Reflects the weighted average price of 1,500 common shares sold by the reporting person in multiple transactions on September 8, 2025 with sale prices ranging from $104.15 to $104.18 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001415889-25-023394 · form4-09022025_080930.xml · derivative · entry 3

Stellato Paul A · CIK 0001714585 · VP, Controller, CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,281 shares

Expires 2025-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

SEC source: 0001415889-25-023394 · form4-09022025_080930.xml · nonDerivative · entry 2

Stellato Paul A · CIK 0001714585 · VP, Controller, CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,710

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001415889-25-023394 · form4-09022025_080930.xml · nonDerivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller, CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,112

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 59 shares acquired under the Employee Stock Purchase Plan on June 30, 2025.

SEC source: 0001415889-25-022439 · form4-08202025_080836.xml · nonDerivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,333

SEC source: 0001062993-25-014300 · form4.xml · derivative · entry 1

Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Bus.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,870

Underlying: Common Stock · 29,870 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: One-third of the RSUs shall vest on each of August 1, 2026, August 1, 2027 and August 1, 2028.

F2 · derivative.expiration_date: One-third of the RSUs shall vest on each of August 1, 2026, August 1, 2027 and August 1, 2028.

SEC source: 0001062993-25-012545 · form4.xml · derivative · entry 3

VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,631 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: The remaining 2,631 RSUs vested on July 1, 2025.

F3 · derivative.expiration_date: The remaining 2,631 RSUs vested on July 1, 2025.

SEC source: 0001062993-25-012545 · form4.xml · nonDerivative · entry 2

VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,473

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

SEC source: 0001062993-25-012545 · form4.xml · nonDerivative · entry 1

VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,165

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001062993-25-012475 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,206.217

Underlying: Common Stock · 301.833 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

SEC source: 0001062993-25-012474 · form4.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,197.03

Underlying: Common Stock · 150.916 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0001062993-25-012463 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,848.064

Underlying: Common Stock · 370.431 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

SEC source: 0001062993-25-012469 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,894.007

Underlying: Common Stock · 466.469 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

SEC source: 0001062993-25-012459 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,505.352

Underlying: Common Stock · 370.431 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.